Apparent Diffusion Coefficients of Metabolites in Patients with MELAS Using Diffusion-Weighted MR Spectroscopy

References

1. 1.↵
   1. Stejskal EO,
   2. Tanner JE

   . Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys 1965;42:288–92

   CrossRefWeb of Science
2. 2.↵
   1. Busza AL,
   2. Allen KL,
   3. King MD,
   4. et al

   . Diffusion-weighted imaging studies of cerebral ischemia in gerbils: potential relevance to energy failure. Stroke 1992;23:1602–12

   Abstract/FREE Full Text
3. 3.↵
   1. Schaefer PW,
   2. Grant PE,
   3. Gonzalez RG

   . Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331–45

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Liu Z,
   2. Liu X,
   3. Hui L,
   4. et al

   . The appearance of ADCs in the non-affected areas of the patients with MELAS. Neuroradiology 2011;53:227–32

   CrossRefPubMed
5. 5.↵
   1. Neumann-Haefelin T,
   2. Wittsack HJ,
   3. Wenserski F,
   4. et al

   . Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591–97

   Abstract/FREE Full Text
6. 6.↵
   1. Wick M,
   2. Nagatomo Y,
   3. Prielmeier F

   . Alteration of intracellular metabolite diffusion in rat brain in vivo during ischemia and reperfusion. Stroke 1995;26:1930–34

   Abstract/FREE Full Text
7. 7.↵
   1. Szafer A,
   2. Zhong J,
   3. Anderson AW,
   4. et al

   . Diffusion-weighted imaging in tissues: theoretical models. NMR Biomed 1995;8:289–96

   PubMedWeb of Science
8. 8.↵
   1. Gujar SK,
   2. Maheshwari S,
   3. Bjorkman-Burtscher I,
   4. et al

   . Magnetic resonance spectroscopy. J Neuroophthalmol 2005;25:217–26

   CrossRefPubMed
9. 9.↵
   1. Hajek M,
   2. Dezortova M

   . Introduction to clinical in vivo MR spectroscopy. Eur J Radiol 2008;67:185–93

   CrossRefPubMed
10. 10.↵
    1. Posse S,
    2. Cuenod CA,
    3. Le Bihan D

    . Human brain: proton diffusion MR spectroscopy. Radiology 1993;188:719–25

    PubMedWeb of Science
11. 11.↵
    1. Harada M,
    2. Uno M,
    3. Hong F,
    4. et al

    . Diffusion-weighted in vivo localized proton MR spectroscopy of human cerebral ischemia and tumor. NMR Biomed 2002;15:69–74

    CrossRefPubMed
12. 12.↵
    1. Ellegood J,
    2. Hanstock CC,
    3. Beaulieu C

    . Trace apparent diffusion coefficients of metabolites in human brain using diffusion weighted magnetic resonance spectroscopy. Magn Reson Med 2005;53:1025–32

    CrossRefPubMed
13. 13.↵
    1. Ellegood J,
    2. Hanstock CC,
    3. Beaulieu C

    . Diffusion tensor spectroscopy (DTS) of human brain. Magn Reson Med 2006;55:1–8

    CrossRefPubMed
14. 14.↵
    1. Merboldt KD,
    2. Horstermann D,
    3. Hanicke W,
    4. et al

    . Molecular self-diffusion of intracellular metabolites in rat brain in vivo investigated by localized proton NMR diffusion spectroscopy. Magn Reson Med 1993;29:125–29

    PubMed
15. 15.↵
    1. Wick M,
    2. Nagatomo Y,
    3. Prielmeier F,
    4. et al

    . Alteration of intracellular metabolite diffusion in rat brain in vivo during ischemia and reperfusion. Stroke 1995;26:1930–33

    Abstract/FREE Full Text
16. 16.↵
    1. Abe O,
    2. Okubo T,
    3. Hayashi N,
    4. et al

    . Temporal changes of the apparent diffusion coefficients of water and metabolites in rats with hemispheric infarction: experimental study of transhemispheric diaschisis in the contralateral hemisphere at 7 Tesla. J Cereb Blood Flow Metab 2000;20:726–35

    PubMedWeb of Science
17. 17.↵
    1. DiMauro S,
    2. Schon EA

    . Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656–68

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Hanna MG,
    2. Nelson IP,
    3. Morgan-Hughes JA,
    4. et al

    . MELAS: a new disease-associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry 1998;65:512–17

    Abstract/FREE Full Text
19. 19.↵
    1. Iizuka T,
    2. Sakai F,
    3. Suzuki N,
    4. et al

    . Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002;59:816–24

    Abstract/FREE Full Text
20. 20.↵
    1. Ohama E,
    2. Ohara S,
    3. Ikuta F,
    4. et al

    . Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226–33

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Takahashi N,
    2. Shimada T,
    3. Murakami Y,
    4. et al

    . Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am J Med Sci 2005;329:265–66

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Oppenheim C,
    2. Galanaud D,
    3. Samson Y,
    4. et al

    . Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000;69:248–50

    Abstract/FREE Full Text
23. 23.↵
    1. Nicolay K,
    2. Braun KPJ,
    3. de Graaf RA,
    4. et al

    . Diffusion NMR spectroscopy. NMR Biomed 2001;14:94–111

    CrossRefPubMedWeb of Science
24. 24.↵
    1. van der Toorn A,
    2. Dijkhuizen RM,
    3. Tulleken CA,
    4. et al

    . Diffusion of metabolites in normal and ischemic rat brain measured by localized 1H MRS. Magn Reson Med 1996;36:914–22

    PubMedWeb of Science
25. 25.↵
    1. Haase A,
    2. Frahm J,
    3. Hanicke W,
    4. et al

    . 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341–44

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Dreher W,
    2. Busch E,
    3. Leibfritz D

    . Changes in apparent diffusion coefficients of metabolites in rat brain after middle cerebral artery occlusion measured by proton magnetic resonance spectroscopy. Magn Reson Med 2001;45:383–89

    CrossRefPubMed
27. 27.↵
    1. Assaf Y,
    2. Cohen Y

    . In vivo and in vitro bi-exponential diffusion of N-acetyl aspartate (NAA) in rat brain: a potential structural probe? NMR Biomed 1998;11:67–74

    CrossRefPubMed
28. 28.↵
    1. Moffett JR,
    2. Namboodiri MA,
    3. Cangro CB,
    4. et al

    . Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131–34

    PubMedWeb of Science
29. 29.↵
    1. Patel TB,
    2. Clark JB

    . Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 1979;184:539–46

    Abstract/FREE Full Text
30. 30.↵
    1. Arun P,
    2. Moffett JR,
    3. Namboodiri MA

    . Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Neurochem Int 2009;55:219–25. Epub 2009 Mar 17

    CrossRefPubMed
31. 31.↵
    1. Boulanger Y,
    2. Labelle M,
    3. Khiat A

    . Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Res Rev 2000;33:380–89

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Wyss M,
    2. Kaddurah-Daouk R

    . Creatine and creatinine metabolism. Physiol Rev 2000;80:1107–213

    Abstract/FREE Full Text
33. 33.↵
    1. Castillo M,
    2. Kwock L,
    3. Mukherji SK

    . Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15

    PubMedWeb of Science
34. 34.↵
    1. Pasantes-Morales H,
    2. Tuz K

    . Volume changes in neurons: hyperexcitability and neuronal death. Contrib Nephrol 2006;152:221–40

    PubMed
35. 35.↵
    1. Lindroos MM,
    2. Borra RJ,
    3. Parkkola R,
    4. et al

    . Cerebral oxygen and glucose metabolism in patients with mitochondrial m. 3243A4G mutation. Brain 2009:132(pt 12);3274–3284

    Abstract/FREE Full Text
36. 36.↵
    1. Iizuka T,
    2. Sakai F,
    3. Ide T,
    4. et al

    . Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS: implication of neurovascular cellular mechanism. J Neurol Sci 2007;257:126–38

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Yonemura K,
    2. Hasegawa Y,
    3. Kimura K,
    4. et al

    . Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol 2001;22:269–72

    Abstract/FREE Full Text
38. 38.↵
    1. Castillo M,
    2. Kwock L,
    3. Green C

    . MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995;16:233–39

    Abstract/FREE Full Text
39. 39.↵
    1. Ducreux D,
    2. Nasser G,
    3. Lacroix C,
    4. et al

    . MR diffusion tensor imaging, fiber tracking, and single-voxel spectroscopy findings in an unusual MELAS case. AJNR Am J Neuroradiol 2005;26:1840–44

    Abstract/FREE Full Text
40. 40.↵
    1. Katayama Y,
    2. Maeda K,
    3. Iizuka T

    . Accumulation of oxidative stress around the stroke-like lesions of MELAS patients. Mitochondrion 2009;9:306–13. Epub 2009 Apr 23

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Gilchrist JM,
    2. Sikirica M,
    3. Stopa E,
    4. et al

    . Adult-onset MELAS evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes. Stroke 1996;27:1420–23

    Abstract/FREE Full Text
42. 42.↵
    1. Betts J,
    2. Jaros E,
    3. Perry RH,
    4. et al

    . Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006;32:359–73

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Tanahashi C,
    2. Nakayama A,
    3. Yoshida M,
    4. et al

    . MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol 2000;99:31–38

    CrossRefPubMed
44. 44.↵
    1. Mizukami K,
    2. Sasaki M,
    3. Suzuki T,
    4. et al

    . Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol 1992;83:449–52

    CrossRefPubMed
45. 45.↵
    1. Burgoyne LA

    . The mechanisms of pyknosis: hypercondensation and death. Exp Cell Res 1999;248:214–22

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Liess C,
    2. Radda GK,
    3. Clarke K

    . Metabolite and water apparent diffusion coefficients in the isolated rat heart: effects of ischemia. Magn Reson Med 2000;44:208–14

    CrossRefPubMedWeb of Science